CATHAL FRIEL has been making a lot of bold moves as executive chairman of Open Orphan, such as the company’s strategic decision in March 2020 to develop a Covid-19 challenge test model. The aim was to elaborate on the design of a characterisation study to understand how to use the virus for a vaccine and… Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!